Skip to main content

Want a detailed portfolio tracker?

Fortrea (FTRE) P/E (2023 - 2026)

Fortrea (FTRE) P/E from Jul 7, 2023 to Jul 21, 2026. The TTM Fortrea (FTRE) P/E is -3.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Fortrea (FTRE)

YearP/EChange
2026-3.66+130.34%
2025-1.59-68.78%
2024-5.08-114.74%
202334.47N/A

Comparison Fortrea (FTRE) P/E with competitors

Fortrea (FTRE) P/E is -3.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.12%
ENLVEnlivex Ltd0.07-102.05%
FGENFibroGen Inc0.24-106.57%
CHRSCoherus Biosciences Inc0.85-123.21%
FBIOFortress Biotech Inc0.95-125.96%
ORMPOramed Pharmaceuticals Inc1.50-141.12%
AGENAgenus Inc3.01-182.33%
INVAInnoviva Inc3.15-186.29%
VXRTVaxart Inc3.55-197.11%
CRMDCorMedix Inc3.63-199.26%
CVACCureVac N.V.4.45-221.62%
GLPGGalapagos NV4.86-232.93%
SRPTSarepta Therapeutics Inc4.88-233.56%
ABEOAbeona Therapeutics Inc5.39-247.39%
ABUSArbutus Biopharma Corp5.60-253.08%
ZVRAZevra Therapeutics Inc5.89-261.06%
SPROSpero Therapeutics Inc6.23-270.39%
CGENCompugen Ltd6.31-272.73%
RIGLRigel Pharmaceuticals6.87-288.00%
SLXNSilexion Therapeutics Corp7.30-299.60%
OMEROmeros Corporation9.26-353.29%
AUPHAurinia Pharmaceuticals Inc9.58-362.22%
PLXProtalix BioTherapeutics Inc10.89-397.95%
ACADAcadia Pharmaceuticals Inc11.73-420.86%
TBPHTheravance Biopharma Inc12.26-435.46%
ADMAAdma Biologics Inc12.42-439.73%
HRMYHarmony Biosciences Holdings Inc13.82-478.08%
SABSSAB Biotherapeutics Inc14.14-486.73%
NAGENiagen Bioscience Inc14.82-505.38%
INCYIncyte Corp15.82-532.86%
REGNRegeneron Pharmaceuticals Inc15.86-533.80%
PBYIPuma Biotechnology Inc17.32-573.71%
CPRXCatalyst Pharmaceuticals Inc17.44-577.09%
EXELExelixis Inc17.54-579.79%
TGTXTG Therapeutics Inc18.97-618.86%
MDXGMimedx Group Inc20.55-662.26%
XOMAXOMA Royalty Corp22.87-725.81%
ARGXArgen X SE24.30-764.75%
CTMXCytomX Therapeutics Inc24.82-779.06%
XOMAOXOMA Royalty Corp25.34-793.38%
HALOHalozyme Therapeutics Inc25.62-801.01%
XOMAPXOMA Royalty Corp25.67-802.28%
VRTXVertex Pharmaceuticals Inc27.99-865.88%
RPRXRoyalty Pharma plc - Class A28.69-884.83%
SLNOSoleno Therapeutics Inc29.02-893.80%
ASNDAscendis Pharma A/S30.09-923.08%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1137.20%
APLSApellis Pharmaceuticals Inc39.02-1167.54%
BMRNBiomarin Pharmaceutical Inc42.21-1254.83%
KRYSKrystal Biotech Inc45.34-1340.51%
ONCBeiGene Ltd69.54-2002.49%
PHARPharming Group N.V.75.03-2152.55%
TECHBio-Techne Corp101.96-2889.38%
VCELVericel Corp109.92-3107.23%
ALNYAlnylam Pharmaceuticals Inc117.96-3327.30%
GMABGenmab140.29-3938.08%
TLXTelix Pharmaceuticals Ltd162.15-4536.19%
CORTCorcept Therapeutics Inc212.86-5923.37%